Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections.
Eldorado Gold, Teekay Tankers, Tetraphase Pharmaceuticals, and Ohr Pharmaceuticals all posted new 52-week lows Tuesday.
Treehouse Foods, CYS Investments, Baker Hughes, and Tetraphase Pharmaceuticals all posted new 52-week lows Thursday.
Tetraphase Pharmaceuticals, Neovasc, Tanger Factory Outlet, and Baker Hughes all posted new 52-week lows Wednesday.
Tetraphase Pharmaceuticals saw its shares get cut in half on Wednesday after the firm provided an update on its late-stage clinical trial for the treatment of urinary tract infections.
Tetraphase Pharmaceuticals saw its shares pull back on Friday after the company announced that it has priced a secondary offering.
Tetraphase Pharmaceuticals saw its shares make a solid gain early on Wednesday after the company announced an exclusive licensing agreement in Asia.
The top analyst upgrades, downgrades and initiations seen on Monday included Chipotle Mexican Grill, Delphi Technologies, Dollar General, Facebook, Ingersoll-Rand, Nike, Okta and Quest Diagnostics.
The top analyst upgrades, downgrades and other research calls from Monday include CalAmp, Fiat Chrysler, Lowe's, Plains All American and Ulta Beauty.
The top analyst upgrades, downgrades and other research calls from Wednesday include Avis Budget, Blue Apron, Chipotle Mexican Grill, Domino's, Northrop Grumman, Pepsico, Rio Tinto, T-Mobile and...
The top analyst upgrades, downgrades and other research calls from Monday include American Express, Cisco, First Solar, Goldman Sachs, Nasdaq, Shopify, SunPower and Workday.
The top analyst upgrades, downgrades and other research calls from Tuesday include Agilent, Apple, Citigroup, Exxon, M&T Bank, Snap, Toyota and Twitter.
A new SunTrust Robinson Humphrey research report focuses in on biotech companies that have upcoming clinical data that could prove to be huge.
Source: ThinkstockSeptember 9, 2015: Here are four stocks trading with heavy volume among 64 equities making new 52-week lows today.Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) dropped nearly 80%...
Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk...